A controlled cohort study of sickness absence and disability pension in colorectal cancer survivors

Authors

  • Beate K. Hauglann National Resource Center for Late Effects after Cancer, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway
  • Jūratė Šaltytė Benth Faculty of Medicine, University of Oslo, Oslo, Norway; Institute of Clinical Medicine, Campus Ahus, University of Oslo, Oslo, Norway; HØKH, Research Centre, Akershus University Hospital, Nordbyhagen, Norway
  • Sophie D. Fosså National Resource Center for Late Effects after Cancer, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway
  • Kjell M. Tveit Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway
  • Alv A. Dahl National Resource Center for Late Effects after Cancer, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway

DOI:

https://doi.org/10.3109/0284186X.2013.844354

Abstract

Purpose. To investigate long-term development of sickness absence and disability pension among colorectal cancer (CRC) survivors compared to matched cancer-free controls, and to assess to what degree socio-demographic and disease characteristics influence these outcomes. Patients and methods. In a register-based cohort study with data from the Cancer Registry of Norway and longitudinal data from other national registries, 740 patients with CRC diagnosed 1992–1996 at the age 45–54 years were observed up to 14 years post-diagnosis. Also 740 matched controls were observed over the same time period. Results. During the first year after diagnosis, 85% of the CRC survivors were on sick-leave at some point, compared to 19% of the controls. Among survivors with localized cancer, 21% were on sick-leave 12 months after diagnosis, versus 33% with regional, and 52% with distant cancer. Survivors with rectum cancer were more likely than colon cancer survivors to be on sick-leave the first year after diagnosis (OR 2.53, 95% CI 1.61–3.98). CRC survivors were at higher risk for disability pension (DP) than controls, depending on extent of disease. Hazard ratios for DP were 1.67 (95% CI 1.13–2.46) for survivors with localized cancer, 3.12 (95% CI 2.06–4.72) for regional, and 10.13 (95% CI 4.17–24.62) for distant cancer, respectively. In survivors, distant cancer, low level of education, not having children < 18 years in the household, pre-diagnostic sick-leave and not being employed at diagnosis were associated with increased likelihood for DP. Conclusion. A considerable proportion of CRC survivors, for years after diagnosis, will experience reduced work ability compared to controls. Rehabilitation and workplace adjustment to reduce sickness absence and improve work ability should be a long-term concern.

Downloads

Download data is not yet available.

Downloads

Published

2014-06-01

How to Cite

Hauglann, B. K., Šaltytė Benth, J., Fosså, S. D., Tveit, K. M., & Dahl, A. A. (2014). A controlled cohort study of sickness absence and disability pension in colorectal cancer survivors. Acta Oncologica, 53(6), 735–743. https://doi.org/10.3109/0284186X.2013.844354